摘要
通过考据《伤寒杂病论》原文,从主治证候、配伍应用探讨经方中当归的运用规律,提出:①当归在《伤寒论》中用于厥阴病篇4方,主治证候皆涉及血分,配伍温热药、泻火解毒药,符合厥阴病阴尽阳生、寒热错杂的病机特点;②《金匮要略》中含当归的经方主要见于妇人三篇,所述患者多见有不同程度的腹痛,用药常与芍药、川芎配伍,若主治病证伴有虚损之证,当加入生地黄,且须配伍山药、人参、阿胶等补虚之品,可知四物汤的功效不拘于补血,需结合药量比例及组方配伍;③当归配伍升麻用治咽痛。
Based on the original text of Treatise on Cold Damage and Miscellaneous Diseases,this essay aims to analyze the application regularity of Danggui(Angelicae Sinensis Radix) in classical prescriptions from the aspects of indications and compatibility.(1)In Treatise on Cold Damage,Danggui is used in four prescriptions of Jueyin chapter. The indications involves blood aspect,compatible with warm and hot herbs,medicinals for purging fire and removing toxin,which is consistent with the pathogenesis characteristics of Jueyin disease,yin exhaustion and yang generation,cold and heat in complexity.(2)Classical formulas containing Danggui in Synopsis of Golden Chamber are mainly found in three chapters focused on gynecological diseases. The patients mentioned in the three chapters often have abdominal pain of different degree.Danggui is often used in combination with Shaoyao(Paeoniae Radix Alba) and Chuanxiong(Chuanxiong Rhizoma). If the indication is accompanied by deficiency syndrome,Dihuang(Rehmannia Radix) should be added and combined with medicinals for tonifying deficiency such as Shanyao( Dioscorea Panthaicae Rhizoma), Renshen( Ginseng Radix Et Rhizoma),Ejiao(Asini Corii Colla). It can be known that the efficacy of Siwu Decoction is not limited to nourish blood,but should be combined with dosage ratio and prescription compatibility.(3)Danggui combined with Shengma(Cimicifugae Rhizoma) are used for sore throat.
作者
阚遵琪
闫文丽
曲夷
KAN Zunqi;YAN Wenli;QU Yi(Shangdong University of Traditional Chinese Medicine,Jinan 250355,China)
出处
《山东中医药大学学报》
2020年第5期509-513,共5页
Journal of Shandong University of Traditional Chinese Medicine
基金
国家中医管理局齐鲁伤寒流派传承工作室建设项目(编号:LPGZS2012-34)
山东省中医经典名方协同创新中心项目(山东中医药大学)。
关键词
当归
经方
《伤寒杂病论》
配伍
用量
适应证
临床应用
Danggui
classical formulas
Treatise on Cold Damage and Miscellaneous Diseases
compatibility
dosage
indication
clinical application
